These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33369212)

  • 1. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months.
    Foulon-Pinto G; Jourdi G; Perrin J; Abdoul J; Paris G; Gouin-Thibault I; Curis E; Lecompte T; Siguret V
    Int J Lab Hematol; 2021 Aug; 43(4):821-830. PubMed ID: 33369212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST-Genesia.
    Talon L; Sinegre T; Lecompte T; Pereira B; Massoulié S; Abergel A; Lebreton A
    J Thromb Haemost; 2020 Sep; 18(9):2177-2190. PubMed ID: 32558351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.
    Douxfils J; Morimont L; Bouvy C; de Saint-Hubert M; Devalet B; Devroye C; Dincq AS; Dogné JM; Guldenpfennig M; Baudar J; Larock AS; Lessire S; Mullier F
    J Thromb Haemost; 2019 Aug; 17(8):1273-1287. PubMed ID: 31063645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability.
    Siguret V; Abdoul J; Delavenne X; Curis E; Carlo A; Blanchard A; Salem JE; Gaussem P; Funck-Brentano C; Azizi M; Mismetti P; Loriot MA; Lecompte T; Gouin-Thibault I
    J Thromb Haemost; 2019 Oct; 17(10):1670-1682. PubMed ID: 31215111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients.
    Foulon-Pinto G; Lafuente-Lafuente C; Jourdi G; Guen JL; Tall F; Puymirat E; Delrue M; Rivière L; Ketz F; Gouin-Thibault I; Mullier F; Gaussem P; Pautas E; Lecompte T; Curis E; Siguret V
    Thromb Haemost; 2023 Apr; 123(4):402-414. PubMed ID: 36395818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram.
    Helin TA; Lemponen M; Lassila R; Joutsi-Korhonen L
    Res Pract Thromb Haemost; 2021 Mar; 5(3):439-446. PubMed ID: 33870029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Thrombin Generation Methods, CAT and ST-Genesia, in Liver Transplant Patients.
    Roullet S; Labrouche S; Freyburger G
    Thromb Haemost; 2019 Jun; 119(6):899-905. PubMed ID: 31005063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
    Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
    Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.
    Ninivaggi M; de Laat-Kremers RMW; Carlo A; de Laat B
    Res Pract Thromb Haemost; 2021 Jan; 5(1):187-196. PubMed ID: 33537543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experience.
    Góralczyk T; Papuga-Szela E; Żuk J; Undas A
    Pol Arch Intern Med; 2018 May; 128(5):324-326. PubMed ID: 29768395
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability.
    Calzavarini S; Brodard J; Quarroz C; Maire L; Nützi R; Jankovic J; Rotondo LC; Giabbani E; Fiedler GM; Nagler M; Angelillo-Scherrer A
    Res Pract Thromb Haemost; 2019 Oct; 3(4):758-768. PubMed ID: 31624796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of direct factor IIa and factor Xa inhibitors in protein C-deficient plasma detected using thrombin generation and viscoelastometry assays.
    Aungraheeta R; FitzGibbon L; Reilly-Stitt C; Mumford AD
    Int J Lab Hematol; 2020 Apr; 42(2):126-133. PubMed ID: 31756037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement.
    Helin TA; Virtanen L; Manninen M; Leskinen J; Leppilahti J; Joutsi-Korhonen L; Lassila R
    J Thromb Thrombolysis; 2017 May; 43(4):562-569. PubMed ID: 28315166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system.
    Pfrepper C; Metze M; Siegemund A; Klöter T; Siegemund T; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):619-627. PubMed ID: 32548561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements of endogenous thrombin potential using the CAT method in cats: Reference values and influence of the direct factor Xa inhibitor apixaban.
    Mischke R; Teuber M; Tiede A
    Res Vet Sci; 2019 Dec; 127():113-121. PubMed ID: 31693942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban.
    Jourdi G; Siguret V; Martin AC; Golmard JL; Godier A; Samama CM; Gaussem P; Gouin-Thibault I; Le Bonniec B
    Thromb Haemost; 2015 Jul; 114(1):78-86. PubMed ID: 25761505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibrated automated thrombogram II: removing barriers for thrombin generation measurements.
    Giesen PLA; Gulpen AJW; van Oerle R; Ten Cate H; Nagy M; Spronk HMH
    Thromb J; 2021 Aug; 19(1):60. PubMed ID: 34454531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method.
    Du S; Harenberg J; Krämer S; Krämer R; Wehling M; Weiss C
    Ther Drug Monit; 2015 Jun; 37(3):375-80. PubMed ID: 25525760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa.
    Bourdin M; Perrotin D; Mathieu O; Herve T; Depasse F; Lu G; Conley PB; Contant G
    Int J Lab Hematol; 2021 Aug; 43(4):795-801. PubMed ID: 34092030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.